Key Takeaways WAT beat Q4 estimates with EPS up 10.5% and sales rising 7% year over year. Pharma and Industrial sales rose 8%, while Europe revenues climbed 13% reported.WAT guides 2026 EPS to $14.30-$14.50 on 5.5-7% constant currency sales growth.Waters Corporation (WAT) reported fourth-quarter 2025 non-GAAP earnings of $4.53 per share, which beat the Zacks Consensus Estimate by 0.67% and increased 10.5% year over year. Net sales of $932.4 million topped the Zacks Consensus Estimate by 0.55%. The figure in ...

Core Viewpoint - SiriusPoint (SPNT) is anticipated to show improvements in both revenue and earnings for the fourth quarter of 2025, with a revenue estimate of $776.1 million, reflecting a 26.6% year-over-year growth, and earnings expected at 54 cents per share, indicating a significant year-over-year growth of 515.4% [1][7]. Financial Performance - SiriusPoint has a history of exceeding earnings expectations, having beaten the Zacks Consensus Estimates in three quarters of 2025, with an average surprise of 49.16% [2]. - The Earnings ESP for SPNT stands at 0.00%, as both the Most Accurate Estimate and the Zacks Consensus Estimate are at 54 cents per share [4]. Factors Influencing Q4 Results - The fourth-quarter results are likely to benefit from improved performance in both the Insurance & Services and Reinsurance segments, with premium growth driven by the expansion of Surety and growth in Accident & Health (A&H) lines [5][6]. - An increase in expenses is expected due to loss and loss adjustment expenses, but prudent underwriting and a less active catastrophe environment may improve the combined ratio [6]. Stock Performance and Valuation - SPNT's stock has outperformed the industry, sector, and the S&P 500 in the fourth quarter of 2025 [10]. - The stock is currently trading at a price-to-book ratio of 1.2, which is lower than the industry average of 2.61 [11].

Core Viewpoint - Sanofi has announced a leadership change, appointing Belén Garijo as the new CEO effective April 29, 2026, following the decision not to renew the mandate of current CEO Paul Hudson, which has led to a 4.5% drop in shares on February 12, 2026 [1][7]. Leadership Change - Paul Hudson's last day as CEO will be February 17, 2026, and Olivier Charmeil will serve as interim CEO until Garijo takes over [2]. - Belén Garijo, a Spanish national, previously served as CEO of Merck KGaA and has held roles at Abbott Laboratories and Sanofi [2]. Market Reaction - Investors have reacted negatively to the sudden CEO change, expressing concerns over Garijo's lack of a proven track record in leading large companies [3]. Stock Performance - Over the past six months, Sanofi's shares have declined by 4.1%, contrasting with a 28.4% increase in the industry [4]. Company Challenges - Sanofi is recognized as a major vaccine manufacturer and has a significant immunology drug, Dupixent, expected to generate around €22 billion in sales by 2030 [5]. - The company has faced setbacks in its research and development (R&D) efforts and pipeline innovation, which may have contributed to the decision for a leadership change [8][9]. - Sanofi has lagged in mergers and acquisitions compared to peers, impacting its growth and diversification [9]. Future Focus - Garijo's primary objectives will include enhancing R&D productivity, governance, and innovation, with the potential to turn around the company's fortunes [10].

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock.That's because, these stocks usually carry above-average risk and volatility. In fact, betting on a stock for which the growth story is actually over or nearing its end could lead to significant loss.However, the task of finding cutting-edge growth stocks is made easy with the help of the Z ...

Core Viewpoint - The article highlights Woodward (WWD) as a promising growth stock, supported by its favorable growth metrics and strong Zacks Rank, indicating potential for outperformance in the market [2][10]. Earnings Growth - Woodward has a historical EPS growth rate of 25.9%, with projected EPS growth of 20.6% for the current year, surpassing the industry average of 20.4% [5][4]. Asset Utilization Ratio - The company has an asset utilization ratio (sales-to-total-assets) of 0.82, indicating it generates $0.82 in sales for every dollar in assets, which is significantly higher than the industry average of 0.57 [6]. Sales Growth - Woodward's sales are expected to grow by 12.7% this year, compared to the industry average of 9.6%, showcasing its strong sales growth potential [7]. Earnings Estimate Revisions - The current-year earnings estimates for Woodward have increased by 9.4% over the past month, reflecting a positive trend in earnings estimate revisions, which is correlated with stock price movements [8]. Overall Positioning - Woodward has achieved a Zacks Rank of 1 (Strong Buy) and a Growth Score of B, positioning it well for potential outperformance in the growth investment space [10].

Core Insights - DexCom, Inc. (DXCM) reported Q4 2025 adjusted EPS of 68 cents, exceeding the Zacks Consensus Estimate of 65 cents by 4.6%, and up from 45 cents in the prior-year quarter [1] - Full-year adjusted EPS was $2.09, reflecting a 27.4% increase from 2024 [1] - GAAP net income per share for Q4 was also 68 cents, up from 38 cents year-over-year [1][2] Revenue Performance - Total revenues for Q4 grew 13% year-over-year to $1.26 billion, surpassing the Zacks Consensus Estimate by 0.6% [3] - Full-year revenues for 2025 increased by 16% to $4.66 billion [4] - U.S. revenues, accounting for 70.8% of total revenues, rose 11% to $891.5 million, while international revenues improved 18% to $368.1 million [5] Margin and Operating Income - Adjusted gross profit reached $799.8 million, a 20.9% increase from the prior-year quarter, with an adjusted gross margin of 63.5%, up 410 basis points year-over-year [9] - Total adjusted operating income was $331.5 million, up 58.2% from the previous year, with an adjusted operating margin of 26.3%, an increase of 750 basis points [10] Financial Position - As of the end of Q4, the company had cash, cash equivalents, and marketable securities totaling $2 billion, down from $3.32 billion in Q3 2025 [11] - Total assets were reported at $6.34 billion, a decrease from $7.5 billion [11] Future Guidance - For 2026, DexCom expects revenues between $5.16 billion and $5.25 billion, indicating 11-13% growth year-over-year [12] - The company anticipates an adjusted gross margin of approximately 63-64% and an adjusted operating margin of about 22-23% [12] Strategic Developments - The nationwide launch of the G7 15-Day system is expected to enhance customer experience and drive growth [8] - The company is preparing for potential Medicare coverage for type 2 non-insulin users, which could significantly expand its market [19] - The G7 system's improvements in accuracy and reliability are expected to support ongoing adoption and market share growth [15]

Core Insights - Eversource Energy (ES) reported fourth-quarter 2025 adjusted earnings of $1.12 per share, exceeding the Zacks Consensus Estimate of $1.10 by 1.82% and reflecting a 10.9% increase from $1.01 in the same quarter last year [1] - Total revenues for 2025 were $3.37 billion, falling short of the Zacks Consensus Estimate of $3.41 billion by 1.29%, but representing a 13.4% increase from $2.97 billion in the previous year [2] - The company projected 2026 earnings of $4.80-$4.95 per share and anticipates a long-term EPS growth rate of 5% to 7% through 2030 [8][9] Financial Performance - Total operating expenses were $2.66 billion, up 1.38% from $2.62 billion in the prior year, driven by higher costs in purchased power, natural gas, and maintenance expenses [3] - Operating income surged to $710.5 million, a 104.3% increase from $347.8 million in the year-ago quarter [3] - Interest expenses rose to $331.2 million, up 14.7% from $288.7 million in the previous year [3] Segment Performance - Electric Transmission earnings were $183.7 million, a slight decrease of 0.16% from the prior year due to the absence of a carrying charge benefit [4] - Electric Distribution earnings fell to $95.5 million, down 13.5% from the previous year, impacted by customer credits related to a settlement agreement in Massachusetts [5] - Natural Gas Distribution earnings increased to $123.6 million, up 19.5% from the prior year, attributed to higher revenues from base distribution rate increases [6] - Water Distribution earnings were $7.4 million, down 1.33% from the previous year [6] - Earnings from Eversource Parent & Other Companies amounted to $11.1 million, a significant increase of 132.2% from a loss of $34.5 million in the year-ago quarter [7] Future Outlook - Eversource Energy expects cash from operations to be between $24.2 billion and $24.7 billion from 2026 to 2030 [9] - The company plans to invest $27.8 billion during the same period, including $1.3 billion for its water business [9] - Eversource anticipates distributing dividends of $6.7 billion to $7.2 billion from 2026 to 2030 [9]

Core Viewpoint - EVI Industries, Inc. reported record quarterly results but experienced a significant decline in stock price, indicating a negative investor reaction despite strong financial performance [1] Financial Performance - Earnings per share for the second fiscal quarter reached 15 cents, up from 7 cents in the prior-year period [2] - Revenues increased by 24% year over year to a record $115.3 million [2] - Gross profit rose by 29% to $35.5 million, resulting in a gross margin of 30.8%, compared to 29.7% a year earlier [2] - Operating income surged by 78% year over year to $4.2 million, while net income more than doubled, increasing by 110% to $2.4 million [2] - Adjusted EBITDA for the quarter was $7.7 million, a 49% increase from $5.1 million, representing 6.6% of revenues [3] Management Commentary - CEO Henry M. Nahmad highlighted the long-term vision of transforming EVI into a national leader in the commercial laundry space, attributing success to strategic investments in people, technology, and operational efficiency [4] - The company is committed to a buy-and-build strategy, showcasing a 10-year track record of 30% compound annual revenue growth and 16% net income growth [5] - Nahmad emphasized "disciplined execution and thoughtful capital deployment," reflecting confidence in the company's scalability and resilience [5] Technology and Efficiency Initiatives - EVI reported a 13% improvement in average service response time over the past year, aided by field service technology that facilitated nearly 9,000 service appointments during the quarter [6] - The company is deploying analytics-driven inventory and procurement tools across over 15,000 SKUs to enhance demand planning and reduce order latency [7] Balance Sheet Data - As of Dec. 31, 2025, EVI reported cash of $4.3 million, down from $8.9 million as of June 30, 2025 [8] - Total assets were $315.6 million, with total liabilities of $171.7 million, including $58 million in long-term debt [8] - Shareholders' equity totaled $144 million, indicating a stable capital base amid ongoing investment and acquisition activity [8] Other Developments - EVI continues to be active in acquisitions, reinforcing its role as a consolidator in the commercial laundry distribution industry, with ongoing evaluations of additional targets and partnerships [8] - Cash flow from operations was positive at $5.1 million for the six-month period ended Dec. 31, 2025, despite a planned $12 million inventory buildup [9] - The company paid a $5 million dividend and completed the final payment on the Continental acquisition, maintaining solid liquidity and access to low-cost capital [9]

Auna S.A. (AUNA) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since analysts are still raising their earnings estimates for the company.The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this company, should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in e ...

Core Viewpoint - Lattice Semiconductor (LSCC) is experiencing solid improvements in earnings estimates, which may lead to continued short-term price momentum and a favorable earnings outlook [1][2]. Earnings Estimates - Analysts are increasingly optimistic about Lattice Semiconductor's earnings prospects, driving higher estimates that are expected to reflect positively in the stock price [2]. - The current quarter's earnings estimate is projected at $0.35 per share, representing a 59.1% increase from the previous year, with an 8.66% rise in consensus estimates over the last 30 days [6]. - For the full year, the earnings estimate is expected to be $1.53 per share, indicating a 45.7% increase from the prior year, with four estimates moving higher and a 7.54% boost in consensus estimates [7][8]. Zacks Rank - Lattice Semiconductor has achieved a Zacks Rank 1 (Strong Buy) due to strong agreement among analysts in revising earnings estimates upward, which has historically led to significant outperformance [3][9]. - Stocks with a Zacks Rank 1 (Strong Buy) and 2 (Buy) have been shown to significantly outperform the S&P 500 [9]. Stock Performance - Lattice shares have increased by 17.1% over the past four weeks, indicating investor confidence in the company's earnings growth prospects [10].